vs

Side-by-side financial comparison of Bunge Global (BG) and Intuitive Surgical (ISRG). Click either name above to swap in a different company.

Bunge Global is the larger business by last-quarter revenue ($4.9B vs $2.8B, roughly 1.8× Intuitive Surgical). Intuitive Surgical runs the higher net margin — 29.8% vs 1.9%, a 27.9% gap on every dollar of revenue. On growth, Intuitive Surgical posted the faster year-over-year revenue change (23.0% vs 22.2%). Over the past eight quarters, Intuitive Surgical's revenue compounded faster (17.4% CAGR vs 11.3%).

Bunge Global SA (BUN-ghee) is a global agribusiness and food company, incorporated in Geneva, Switzerland and headquartered in St. Louis, Missouri, United States.

Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S.

BG vs ISRG — Head-to-Head

Bigger by revenue
BG
BG
1.8× larger
BG
$4.9B
$2.8B
ISRG
Growing faster (revenue YoY)
ISRG
ISRG
+0.8% gap
ISRG
23.0%
22.2%
BG
Higher net margin
ISRG
ISRG
27.9% more per $
ISRG
29.8%
1.9%
BG
Faster 2-yr revenue CAGR
ISRG
ISRG
Annualised
ISRG
17.4%
11.3%
BG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BG
BG
ISRG
ISRG
Revenue
$4.9B
$2.8B
Net Profit
$95.0M
$826.0M
Gross Margin
20.7%
66.1%
Operating Margin
1.8%
Net Margin
1.9%
29.8%
Revenue YoY
22.2%
23.0%
Net Profit YoY
-84.2%
17.4%
EPS (diluted)
$-0.02
$2.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BG
BG
ISRG
ISRG
Q1 26
$2.8B
Q4 25
$4.9B
$2.9B
Q3 25
$4.4B
$2.5B
Q2 25
$4.0B
$2.4B
Q1 25
$3.7B
$2.3B
Q4 24
$4.0B
$2.4B
Q3 24
$3.9B
$2.0B
Q2 24
$3.7B
$2.0B
Net Profit
BG
BG
ISRG
ISRG
Q1 26
$826.0M
Q4 25
$95.0M
$794.8M
Q3 25
$166.0M
$704.4M
Q2 25
$354.0M
$658.4M
Q1 25
$201.0M
$698.4M
Q4 24
$602.0M
$685.7M
Q3 24
$221.0M
$565.1M
Q2 24
$70.0M
$526.9M
Gross Margin
BG
BG
ISRG
ISRG
Q1 26
66.1%
Q4 25
20.7%
66.4%
Q3 25
24.3%
66.4%
Q2 25
18.4%
66.3%
Q1 25
16.3%
64.7%
Q4 24
27.0%
68.0%
Q3 24
19.9%
67.4%
Q2 24
17.8%
68.3%
Operating Margin
BG
BG
ISRG
ISRG
Q1 26
Q4 25
1.8%
30.2%
Q3 25
6.2%
30.3%
Q2 25
12.3%
30.5%
Q1 25
7.8%
25.7%
Q4 24
18.3%
30.4%
Q3 24
8.3%
28.3%
Q2 24
2.8%
28.2%
Net Margin
BG
BG
ISRG
ISRG
Q1 26
29.8%
Q4 25
1.9%
27.7%
Q3 25
3.8%
28.1%
Q2 25
8.8%
27.0%
Q1 25
5.5%
31.0%
Q4 24
15.0%
28.4%
Q3 24
5.7%
27.7%
Q2 24
1.9%
26.2%
EPS (diluted)
BG
BG
ISRG
ISRG
Q1 26
$2.28
Q4 25
$-0.02
$2.19
Q3 25
$0.84
$1.95
Q2 25
$2.61
$1.81
Q1 25
$1.48
$1.92
Q4 24
$4.27
$1.89
Q3 24
$1.56
$1.56
Q2 24
$0.48
$1.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BG
BG
ISRG
ISRG
Cash + ST InvestmentsLiquidity on hand
$2.0B
Total DebtLower is stronger
$10.2B
Stockholders' EquityBook value
$15.9B
$17.6B
Total Assets
$44.5B
$20.1B
Debt / EquityLower = less leverage
0.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BG
BG
ISRG
ISRG
Q1 26
Q4 25
$2.0B
$5.9B
Q3 25
$3.2B
$4.9B
Q2 25
$7.1B
$5.3B
Q1 25
$3.9B
$4.5B
Q4 24
$3.8B
$4.0B
Q3 24
$3.0B
$4.2B
Q2 24
$1.3B
$4.8B
Total Debt
BG
BG
ISRG
ISRG
Q1 26
Q4 25
$10.2B
Q3 25
$11.1B
Q2 25
$7.7B
Q1 25
$5.4B
Q4 24
$5.4B
Q3 24
$5.4B
Q2 24
$4.1B
Stockholders' Equity
BG
BG
ISRG
ISRG
Q1 26
$17.6B
Q4 25
$15.9B
$17.8B
Q3 25
$15.8B
$16.9B
Q2 25
$10.9B
$17.8B
Q1 25
$10.6B
$17.1B
Q4 24
$9.9B
$16.4B
Q3 24
$10.1B
$15.6B
Q2 24
$10.0B
$14.7B
Total Assets
BG
BG
ISRG
ISRG
Q1 26
$20.1B
Q4 25
$44.5B
$20.5B
Q3 25
$46.3B
$19.4B
Q2 25
$31.2B
$20.2B
Q1 25
$26.7B
$19.2B
Q4 24
$24.9B
$18.7B
Q3 24
$25.3B
$17.7B
Q2 24
$24.4B
$16.6B
Debt / Equity
BG
BG
ISRG
ISRG
Q1 26
Q4 25
0.64×
Q3 25
0.71×
Q2 25
0.71×
Q1 25
0.51×
Q4 24
0.54×
Q3 24
0.54×
Q2 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BG
BG
ISRG
ISRG
Operating Cash FlowLast quarter
$1.3B
Free Cash FlowOCF − Capex
$809.0M
FCF MarginFCF / Revenue
16.6%
Capex IntensityCapex / Revenue
11.0%
Cash ConversionOCF / Net Profit
14.18×
TTM Free Cash FlowTrailing 4 quarters
$-879.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BG
BG
ISRG
ISRG
Q1 26
Q4 25
$1.3B
$892.5M
Q3 25
$854.0M
$841.0M
Q2 25
$-1.1B
$715.4M
Q1 25
$-285.0M
$581.6M
Q4 24
$1.1B
$822.6M
Q3 24
$1.3B
$706.5M
Q2 24
$-1.5B
$620.5M
Free Cash Flow
BG
BG
ISRG
ISRG
Q1 26
Q4 25
$809.0M
$730.0M
Q3 25
$385.0M
$735.6M
Q2 25
$-1.5B
$560.1M
Q1 25
$-595.0M
$465.0M
Q4 24
$564.0M
$510.6M
Q3 24
$973.0M
$458.6M
Q2 24
$-1.8B
$311.1M
FCF Margin
BG
BG
ISRG
ISRG
Q1 26
Q4 25
16.6%
25.5%
Q3 25
8.8%
29.4%
Q2 25
-36.8%
23.0%
Q1 25
-16.2%
20.6%
Q4 24
14.1%
21.2%
Q3 24
25.1%
22.5%
Q2 24
-47.4%
15.5%
Capex Intensity
BG
BG
ISRG
ISRG
Q1 26
Q4 25
11.0%
5.7%
Q3 25
10.7%
4.2%
Q2 25
10.1%
6.4%
Q1 25
8.5%
5.2%
Q4 24
12.2%
12.9%
Q3 24
9.1%
12.2%
Q2 24
8.0%
15.4%
Cash Conversion
BG
BG
ISRG
ISRG
Q1 26
Q4 25
14.18×
1.12×
Q3 25
5.14×
1.19×
Q2 25
-3.03×
1.09×
Q1 25
-1.42×
0.83×
Q4 24
1.75×
1.20×
Q3 24
6.00×
1.25×
Q2 24
-21.06×
1.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BG
BG

Other Oilseeds Processing And Refining$4.6B95%
Other$251.0M5%
Other Products$3.0M0%

ISRG
ISRG

Instruments and accessories$1.7B61%
Systems$650.7M23%
Services$433.7M16%

Related Comparisons